These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2865 related articles for article (PubMed ID: 7286547)

  • 21. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
    Fidler IJ; Nicolson GL
    Isr J Med Sci; 1978 Jan; 14(1):38-50. PubMed ID: 632082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
    Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
    Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
    Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of B16 melanoma antigen expression by lymphokines and dimethyl sulfoxide.
    Trimpe KL; Zwilling BS
    Cancer Res; 1986 Oct; 46(10):4953-9. PubMed ID: 3756856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma.
    Giacomini P; Veglia F; Cordiali Fei P; Rehle T; Natali PG; Ferrone S
    Cancer Res; 1984 Mar; 44(3):1281-7. PubMed ID: 6692408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
    Fidler IJ; Bucana C
    Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactivity between murine melanoma antigen B700 and a human melanoma-associated antigen (M-66) recognized by autologous antibody: evidence suggesting shared epitopes.
    Toporowicz A; Gersten DM; Hearing VJ; Brown WE; Vlock DR
    Biochim Biophys Acta; 1993 Aug; 1182(1):51-6. PubMed ID: 7688577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
    Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of tumor-associated antigens shed by human melanoma cells in culture.
    Boctor AM; Bystryn JC
    Cancer Res; 1982 Jun; 42(6):2121-5. PubMed ID: 7074593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunogenicity of 2 murine B16 melanoma variants with high metastatic potential].
    Hosni M; Santini R; Deschaux P; Pacheco H
    C R Seances Soc Biol Fil; 1990; 184(1):47-54. PubMed ID: 2150781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syngeneic monoclonal anti-melanoma antibody that inhibits experimental lung metastasis of B16 melanoma.
    Gunji Y; Taniguchi M
    Jpn J Cancer Res; 1986 Jun; 77(6):595-601. PubMed ID: 3089994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
    Koestler TP; Papsidero LD; Nemoto T; Chu TM
    Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Class 1 (unique) tumor antigens of human melanoma: partial purification and characterization of the FD antigen and analysis of a mouse polyclonal antiserum.
    Mattes MJ; Real FX; Furukawa K; Old LJ; Lloyd KO
    Cancer Res; 1987 Dec; 47(24 Pt 1):6614-9. PubMed ID: 2445475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
    Chen ZJ; Yang H; Kageshita T; Ferrone S
    Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomas.
    Hill HZ; Hill GJ; Miller CL; Pfaller M; Weiss K; Galin M
    Cancer Res; 1979 Mar; 39(3):934-9. PubMed ID: 427782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo reexpression of H-2 antigens in B16 melanoma cells.
    Lollini PL; Colombo MP; De Giovanni C; Nicoletti G; Parmiani G; Prodi G; Nanni P
    Exp Clin Immunogenet; 1985; 2(1):14-23. PubMed ID: 3939971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of a monoclonal antibody-defined, melanoma-associated antigen in human sera: correlation of circulating antigen levels with tumor burden.
    Morgan AC; Crane MM; Rossen RD
    J Natl Cancer Inst; 1984 Feb; 72(2):243-9. PubMed ID: 6582312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.
    Hearing VJ; Gersten DM; Montague PM; Vieira WD; Galetto G; Law LW
    J Immunol; 1986 Jul; 137(1):379-84. PubMed ID: 3711669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 144.